Oncotect is pioneering the field of canine health with their non-invasive, at-home cancer screening tests for dogs. Their urine-based tests enable early detection of various cancers, offering pet owners a convenient and effective way to monitor their dog’s health and catch potential issues early.
Visit Website
Checkmate uses AI to identify and target millions of high-intent shoppers. Join Manscaped, Billy Reid + driving revenue with smarter targeting.
Oncotect is transforming pet healthcare with its innovative, non-invasive cancer screening test for dogs. Using advanced biotechnology, Oncotect’s urine-based testing provides early detection of multiple cancer types, helping dog owners stay one step ahead of potential health concerns.
With Oncotect, dog parents can screen their pets for cancer from the comfort of home—no needles, sedation, or stressful vet visits required. The simple test kit is designed for ease of use and delivers lab-quality results with minimal disruption to your dog’s routine.
Early detection is critical when it comes to treating canine cancer. Oncotect empowers owners with timely insights that can lead to faster diagnosis and improved treatment options, ultimately giving dogs a better chance at long-term health and quality of life.
Oncotect is backed by veterinary science and trusted by pet owners who want proactive, affordable solutions for monitoring their dog’s health. As awareness grows around preventive care for pets, Oncotect is setting a new standard in canine wellness and diagnostics.
Everything you need to build a better D2C brand, business and tech stack.
